Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

CzechiaBack to Czechia

Clinical trials in Liberec (Neclenene Mesto)

24 clinical trials in Liberec (Neclenene Mesto), Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.

CzechiaOur site in CzechiaKlinickeTesty.cz(opens in a new tab)
Liberec (Neclenene Mesto) at a glance
24
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

24 trials in Liberec (Neclenene Mesto)

Open in trial search

Chronic kidney disease

Recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB

Acute myocardial infarction

Recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH

Acute respiratory distress syndrome

Recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Human Plasma Gelsolin, Recombinant
  • Sponsor:Bioaegis Therapeutics Inc.

Erythema migrans+1

Recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin
  • Sponsor:Biocodex

Factor VIII deficiency+1

Not yet recruiting
Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Efmoroctocog Alfa
  • Sponsor:Swedish Orphan Biovitrum AB (publ)

Influenza

Not recruiting
Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:65+ years · Healthy volunteers
  • Substances:A/DARWIN/9/2021 (H3N2) - LIKE STRAIN (A/DARWIN/6/2021, IVR-227)
  • Sponsor:Seqirus UK Limited

Dyslipidaemia

Not recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Amgen Inc.

Metabolic dysfunction-associated steatohepatitis+1

Not recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S

Metabolic dysfunction-associated steatohepatitis+1

Not recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Back pain

Not recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Dronabinol
  • Sponsor:Vertanical GmbH

Acute coronary syndrome

Not recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen - Cilag International

Arteriosclerosis

Not recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG

Other cities in Czechia

The busiest research cities in the country

All 158 cities in Czechia

Clinical research in Liberec (Neclenene Mesto)

What the registry says about research in the country

01 Liberec (Neclenene Mesto)
Cardiovascular Diseases
In Liberec, a large share of clinical research focuses on cardiovascular diseases, especially on preventing and treating acute myocardial infarction, heart failure, and stroke risk in people with atrial fibrillation or high overall cardiovascular risk. Testing new ways to reduce major adverse cardiovascular events Studying treatments for acute coronary syndrome and ST-elevation myocardial infarction Evaluating prevention strategies for stroke and systemic embolism Improving care for patients at elevated risk of heart attack or heart failure These studies aim to strengthen prevention and improve treatment effectiveness in people with serious heart-related conditions.
Digestive System and Liver Diseases
Research in digestive system diseases centers on liver health, with studies in non-alcoholic steatohepatitis, alcohol-related liver disease, and cirrhosis. Testing therapies that may reduce liver fibrosis and improve liver function Exploring combinations aimed at better control of liver damage Assessing options for people with advanced chronic liver disease Studying treatment effects in metabolic and alcohol-related liver injury The overall goal is to find better ways to slow liver damage and support long-term liver health.
Neoplasms and Oncology
Oncology trials in this city include studies of prostate cancer and bladder cancer, with attention to both localized and metastatic disease. Evaluating new treatment combinations for high-risk prostate cancer Studying therapies for metastatic castration-sensitive prostate cancer Testing approaches for high-risk non-muscle-invasive bladder cancer Looking for better disease control and longer progression-free survival These studies focus on improving cancer outcomes while expanding treatment options for patients with difficult-to-treat disease.
Respiratory Tract Diseases
Clinical trials in respiratory tract diseases address both chronic and acute conditions, including chronic obstructive pulmonary disease and acute respiratory distress syndrome. Testing therapies to reduce COPD flare-ups Studying treatments for severe breathing failure linked to infection Evaluating supportive options for former smokers with respiratory symptoms Improving outcomes in serious lung inflammation and infection-related illness The research is aimed at easing symptoms, preventing complications, and improving lung function in high-need patients.
Nutritional and Metabolic Diseases
Trials in nutritional and metabolic diseases are mainly directed at obesity-related liver disease and metabolic complications that affect liver and cardiovascular health. Studying therapies that may improve metabolism and reduce liver injury Exploring treatment combinations for people with advanced liver fibrosis Assessing the impact of metabolic control on disease progression Supporting better management of complex long-term metabolic disorders These studies aim to link metabolic treatment with broader benefits for liver and overall health.
Hemic and Lymphatic Diseases
Research in hemic and lymphatic diseases includes studies for hemophilia A and B, focusing on joint health and bleeding-related complications. Assessing joint status in people receiving preventive treatment Monitoring how therapy may protect mobility and reduce joint damage Supporting better long-term management of bleeding disorders Improving quality of life for patients with inherited clotting conditions The research reflects a practical effort to preserve joint function and reduce the burden of recurrent bleeding.
Musculoskeletal Diseases and Pain
Clinical research also covers musculoskeletal diseases, especially chronic non-specific low back pain, a common condition that can be difficult to manage when standard options do not provide enough relief. Testing new approaches for pain reduction Studying treatment response in people with persistent back pain Looking for alternatives when usual non-opioid care is not enough Evaluating ways to improve daily function and comfort These studies are designed to support more effective and better-tolerated pain care.
Virus Diseases and Infection-Related Research
In the area of virus diseases and infection-related care, trials include influenza prevention as well as microbiome-focused research in patients receiving antibiotics for Lyme borreliosis. Evaluating vaccine effectiveness in older adults Studying protection against seasonal influenza Examining how antibiotic use affects the gut microbiota Exploring supportive approaches during treatment for infection The aim is to improve prevention and understand how infection treatments influence the body.
Back to CzechiaAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.